Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000823088 | SCV000963930 | likely benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2024-01-13 | criteria provided, single submitter | clinical testing | |
Molecular Genetics, |
RCV002221253 | SCV002498664 | uncertain significance | Distal myopathy with posterior leg and anterior hand involvement | 2023-03-30 | criteria provided, single submitter | clinical testing | This sequence change is predicted to replace arginine with tryptophan at codon 629 of the FLNC protein (p.(Arg629Trp)). The arginine residue is highly conserved (100 vertebrates, UCSC), and is located in a beta strand in the filamin 4 repeat domain. There is a large physicochemical difference between arginine and tryptophan. The variant is present in a large population cohort at a frequency of 0.003% (rs759376455, 9/280,900 alleles, 0 homozygotes in gnomAD v2.1), and has been reported as a variant of uncertain significance (ClinVar, LOVD). It has not been reported in the relevant medical literature. Multiple lines of computational evidence predict a deleterious effect for the missense substitution (5/6 algorithms). Based on the classification scheme RMH Modified ACMG Guidelines v1.3.2, this variant is classified as a VARIANT OF UNCERTAIN SIGNIFICANCE. Following criteria are met: PP3. |
Revvity Omics, |
RCV001579972 | SCV003833601 | uncertain significance | not provided | 2022-07-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004029126 | SCV005017691 | uncertain significance | Cardiovascular phenotype | 2024-02-26 | criteria provided, single submitter | clinical testing | The p.R629W variant (also known as c.1885C>T), located in coding exon 12 of the FLNC gene, results from a C to T substitution at nucleotide position 1885. The arginine at codon 629 is replaced by tryptophan, an amino acid with dissimilar properties. This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this alteration remains unclear. |
Genome Diagnostics Laboratory, |
RCV001579972 | SCV001809239 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001579972 | SCV001952238 | uncertain significance | not provided | no assertion criteria provided | clinical testing |